PharmPK Discussion - Dissolution, Bioequivalence, Bioavailability

PharmPK Discussion List Archive Index page

On 25 Oct 2004 at 09:09:32, "Browne, Justin" (Justin.Browne.at.parexel.com) sent the message


I am hosting two Dissolution, Bioequivalence, Bioavailability events,
one in
Brussels and one in the US.
Employing Industry Best Practices and Proven Strategies for
Bioequivalence &
Bioavailability Studies: Maximizing Scientific and Technological
Advancements
November 18-19, 2004 Park Hyatt, Brussels Belgium
* 	Featuring In-Depth Coverage of Dissolution Methodologies, IV/IVC,
BCS, Biowaivers, Biorelevant Media, & Food Effects
*     Dissolution Method Development and Validation Incorporating Global
Regulatory Requirements
* 	Designing and Evaluating BA/BE Studies to Overcome Pitfalls &
Prevent Deficiency Letters
* 	Evaluate Emerging Technology Including Using NIR Spectroscopy
Employing Best Practices and Proven Strategies for Dissolution,
Bioequivalence, Bioavailability February 7-8, 2005 Philadelphia, PA
Maximizing Scientific and Technological Advancements
*	Premier event featuring high level renown industry speakers. Focus
includes: Current Regulatory Framework, Developing & *	Validating
Dissolution Methods, IVIVC, Calibration, Poorly Soluble Drugs,
Strategies
for Novel Dosage Forms, Dearation, Surfactants, BCS, Developing
Biorelevant
Dissolution Test Methodology to Facilitate IVIVC and Reduce
Time-to-Market
and *	Technology: Fiber Optic, Process Analytical Technologies,
Automated
Dissolution Methods.
Also check out:
Proven Strategies and Industry Best Practices for CTD/eCTD: Practical
Implementation to Meet Global Requirements
November 8-9, 2004    Park Hyatt Hotel   Philadelphia, PA
Designing & Analyzing Dose Response Clinical Trials: Reducing
Development
Time & Expense
November 15-16, 2004 * Airport Marriott * Philadelphia, PA
Computer & Software Validation and Electronic Document Management:
Evolving
Part 11 Expectations, Industry Best Practices, Proven Strategies,
Emerging
Technology and Risk-Based Approaches
December 2-3, 2004 	Philadelphia, PA
Overcoming Pre-formulation & Formulation Issues: Salt Selection,
Polymorphism  February 7-8, 2005 Philadelphia, PA
Reducing Time to Market and Increasing Efficacy and Improved Drug
Delivery
Join leading experts representing regulatory, academia, and industry to
examine proven strategies for overcoming challenges in Pre-Formulation
and
Formulation. This conference focuses on Salt Selection, Polymorphism,
and
Particle Size. Attendees help speed their companies' products to market
with
insights into emerging scientific and technological solutions, while
ensuring compliance.
Combination Products March 7-8, 2005 in San Diego, CA.
Combination Drugs March 7-8, 2005 in San Diego, CA.
Check out:
http://www.barnettinternational.com/edu-conf1.jsp?
cmdsub=View&txtkeyword=for
more details, or contact me directly
Justin A. Browne
justin.browne.aaa.parexel.com
410-796-7405

Back to the Top

Want to post a follow-up message on this topic? If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Dissolution, Bioequivalence, Bioavailability" as the subject

PharmPK Discussion List Archive Index page